Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teneligliptin as Quadruple Therapy for Type 2 Diabetes
NCT04446026Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Jul 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Teneligliptin with Placebo / Teneligliptin (2 arms). Primary endpoint: Change in Hemoglobin A1c at 12 weeks. Started Jul 2020; status: completed.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04446026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04446026.